Home / Going-concern warnings / Greenwich LifeSciences, Inc.
Filed 2026-06-01 路 Form 10-K 路 Accession 0001493152-26-026651 small
Price before filing: $26.18 (2026-05-29 close, split/dividend-adjusted)
Market cap at flag: $415.3M (2026-06-01) 路 Latest: $212.7M (2026-10-16)
| Window | GLSI | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -9.5% | -1.2% | -8.3% | 2026-07-01 |
| 90 days | -42.9% | +1.7% | -44.6% | 2026-08-31 |
| 180 days | pending | pending | until 2026-11-28 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"As discussed in Note 2 to the financial statements, the Company has suffered recurring losses from operations that raises substantial doubt about its ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Going-concern opinion issued by: MaloneBailey, LLP
Source: independent auditor report in Form 10-K (period 2025-12-31)
Why this score: in auditor's report; also within 90 days: Late annual report (NT 10-K)
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.